These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30561693)

  • 1. Influenza Vaccines After 7 Decades: Still on the Learning Curve.
    Keitel WA; Atmar RL
    J Infect Dis; 2019 Sep; 220(8):1240-1242. PubMed ID: 30561693
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Importance of influenza in the child. Intranasal influenza vaccine: another systematic vaccination?].
    Moraga Llop FA; Campins Martí M
    An Esp Pediatr; 2000 Oct; 53(4):299-304. PubMed ID: 11523509
    [No Abstract]   [Full Text] [Related]  

  • 4. Protection of children against influenza: Emerging problems.
    Principi N; Esposito S
    Hum Vaccin Immunother; 2018 Mar; 14(3):750-757. PubMed ID: 28129049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season.
    Grohskopf LA; Alyanak E; Broder KR; Blanton LH; Fry AM; Jernigan DB; Atmar RL
    MMWR Recomm Rep; 2020 Aug; 69(8):1-24. PubMed ID: 32820746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of adverse events on the projected population benefits and cost-effectiveness of using live attenuated influenza vaccine in children aged 6 months to 4 years.
    Prosser LA; Meltzer MI; Fiore A; Epperson S; Bridges CB; Hinrichsen V; Lieu TA
    Arch Pediatr Adolesc Med; 2011 Feb; 165(2):112-8. PubMed ID: 20921341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of a study of the effectiveness of simultaneous immunization against influenza with live and inactivated vaccines (1980-1983)].
    Zhilova GP; Ignat'eva GS; Orlov VA; Malikova EV; Maksakova VL
    Vopr Virusol; 1986; 31(1):40-4. PubMed ID: 2938336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza: the vaccines.
    Kilbourne ED
    Hosp Pract; 1976 Nov; 11(11):65-70. PubMed ID: 1026617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel.
    Wang Z; Tobler S; Roayaei J; Eick A
    JAMA; 2009 Mar; 301(9):945-53. PubMed ID: 19255113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunological effectiveness of a method for simultaneous immunization against influenza using live and inactivated vaccines].
    Orlov VA; Zhilova GP; Ignat'eva GS; Malikova EV; Efremov BV
    Vopr Virusol; 1982; 27(3):271-5. PubMed ID: 7123907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible reduced effectiveness of the 2009 H1N1 component of live, attenuated influenza vaccine.
    Myers CA; Faix DJ; Blair PJ
    Clin Infect Dis; 2011 Jul; 53(2):207-8. PubMed ID: 21690631
    [No Abstract]   [Full Text] [Related]  

  • 13. [Increase of the immunogenic activity of live influenza vaccine by means of a 3-stage immunization of susceptible persons].
    SMORODINTSEV AA; CHALKINA OM; BUROV SA; IL'IN NA
    Vopr Virusol; 1962; 7():683-8. PubMed ID: 13989642
    [No Abstract]   [Full Text] [Related]  

  • 14. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological effectiveness of live influenza vaccines].
    Serebriakov LV; Rzhanov VE; Semeniuk VG; Stepanchuk VA
    Voen Med Zh; 1974 Oct; (10):54-5. PubMed ID: 4439678
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States.
    Caspard H; Gaglani M; Clipper L; Belongia EA; McLean HQ; Griffin MR; Talbot HK; Poehling KA; Peters TR; Veney N; Ambrose CS
    Vaccine; 2016 Jan; 34(1):77-82. PubMed ID: 26589519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in influenza virus vaccine research.
    Couch RB
    Ann N Y Acad Sci; 1993 Jun; 685():803-12. PubMed ID: 8363288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Increase in the effectiveness of anti-influenza immunization by use of a combination of inactivated and live vaccine].
    Smorodintsev AA; Orlov VA; Ermolaeva OM; Zhilova GP
    Vopr Virusol; 1978; (5):602-7. PubMed ID: 735019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylactic effectiveness of an inactivated formol influenza vaccine].
    Agafonov VI; Perepelkin VS; Chemeris EA; Novikov NL
    Voen Med Zh; 1981 Feb; (2):36-8. PubMed ID: 7233843
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influenza and anti-influenza vaccination].
    De Mol P
    Rev Med Liege; 1997 Sep; 52(9):573-6. PubMed ID: 9441338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.